Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지
DOI QR코드

DOI QR Code

Intractable Coronary Spasm Requiring Percutaneous Coronary Intervention after Coronary Artery Bypass Grafting in a Patient with Moyamoya Disease

  • Kim, Hyeon A (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Young Su (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Wook Sung (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Received : 2020.05.20
  • Accepted : 2020.08.12
  • Published : 2021.04.05
Download PDF
⟨ Previous Next ⟩

Abstract

Moyamoya disease (MMD) is characterized by progressive steno-occlusive lesions of the distal or proximal branch of the internal carotid arteries, and cerebrovascular symptoms are its major complications. Extracranial vascular involvement including the coronary artery has been reported, and some case reports have described variant angina or myocardial infarction. However, no report has yet described a case of myocardial infarction after coronary artery bypass grafting (CABG). Here, we present a patient with MMD who suffered cardiac arrest caused by myocardial infarction due to a coronary spasm after offpump CABG and who was discharged successfully after treatment with a veno-arterial extracorporeal membrane oxygenator and percutaneous coronary intervention.

Keywords

References

  1. Koizumi A, Kobayashi H, Hitomi T, Harada KH, Habu T, Youssefian S. A new horizon of moyamoya disease and associated health risks explored through RNF213. Environ Health Prev Med 2016;21:55-70. https://doi.org/10.1007/s12199-015-0498-7
  2. Bang OY, Chung JW, Kim DH, et al. Moyamoya disease and spectrums of RNF213 vasculopathy. Transl Stroke Res 2020;11:580-9. https://doi.org/10.1007/s12975-019-00743-6
  3. Kim HJ, Jo WM, Rhu SM, Hwang JJ, Sohn YS, Choi YH. Coronary artery disease affected by moyamoya disease. Korean J Thorac Cardiovasc Surg 2002;35:231-4.
  4. Guo DC, Papke CL, Tran-Fadulu V, et al. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am J Hum Genet 2009;84:617-27. https://doi.org/10.1016/j.ajhg.2009.04.007
  5. Nam TM, Jo KI, Yeon JY, Hong SC, Kim JS. Coronary heart disease in moyamoya disease: are they concomitant or coincidence? J Korean Med Sci 2015;30:470-4. https://doi.org/10.3346/jkms.2015.30.4.470
  6. Choi W, Kim YN, Kim KH. Variant angina in moyamoya disease: a correlative etiology and different presentation: a case report. J Med Case Rep 2015;9:86. https://doi.org/10.1186/s13256-015-0537-4
  7. Takaoka K, Yoshimura M, Ogawa H, et al. Comparison of the risk factors for coronary artery spasm with those for organic stenosis in a Japanese population: role of cigarette smoking. Int J Cardiol 2000;72:121-6. https://doi.org/10.1016/S0167-5273(99)00172-2
  8. Tanabe Y, Itoh E, Suzuki K, et al. Limited role of coronary angioplasty and stenting in coronary spastic angina with organic stenosis. J Am Coll Cardiol 2002;39:1120-6. https://doi.org/10.1016/S0735-1097(02)01746-1